TAE Life Sciences (TLS) is a biologically-targeted radiation therapy company focused
on developing novel treatment to improve the lives of patients with difficult-to-treat cancers.
TAE Life Sciences is pushing the boundaries of science to create an innovative biologically targeted radiation therapy for cancer. We are the only company developing both the targeted boron drugs and a neutron beam system for BNCT.
We believe the evolution in BNCT will enable a paradigm shift in cancer care with the potential to improve the lives of patients with difficult-to-treat cancers.
Chief Executive Officer
Chief Science Officer
GM Americas and Global Vice President Marketing
VP Product
Chief Executive Officer
TAE Life Sciences
Chief Executive Officer,
TAE Technologies, Inc.
Co-Founder and President, ARTIS Ventures
Senior Vice President
Medical Affairs & Chief Medical Officer, Varian
Come join a team dedicated to enabling a new hope for cancer patients and their families.
